Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects
Cell Host & Microbe · 2025-06 · 33 (6) · 836-853
DOI: 10.1016/j.chom.2025.04.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Host & Microbe, 2025-06. Verfasst von Xi Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, Center for Obesity and Metabolic Disease Research, School of Basic Medical Sciences, State Key Laborato…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fatty Liver. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 147 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Municipal Outstanding Young Talents.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver disease worldwide. The liver communicates with the intestine, in large part through the gut microbiota. Microbial enzymes are key mediators that affect the progression of MASLD and the more severe metabolic dysfunction-associated steatohepatitis (MASH). These enzymes contribute to the metabolism or biosynthesis of steroids, fatty acids, amino acids, ethanol, choline, and intestinal hormones that contribute to disease progression. Additionally, dysbiosis and functional alterations in the microbiota compromise the intestinal barrier, increasing its permeability to bacterial metabolites and liver exposure to microbial-associated molecular patterns (MAMPs), thereby exacerbating liver inflammation and fibrosis. Furthermore, functional alterations in the gut microbiota can modulate intestinal signaling pathways through metabolites or gut hormones, subsequently affecting hepatic metabolism. A deeper understanding of the roles of the gut microbiota and microbial enzymes in MASH will facilitate the development of personalized treatments targeting specific gut microbes or functional enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, Center for Obesity and Metabolic Disease Research, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing…
- Department of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology, Peking University, Beijing 100191, China. Electronic address: wangkai@bjmu.edu.cn.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Municipal Outstanding Young Talents
Zitieren
APA
Luo, X., Wang, K., & Jiang, C. (2025). Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects. Cell Host & Microbe, 33(6), 836-853. https://doi.org/10.1016/j.chom.2025.04.020
Vancouver
Luo X, Wang K, Jiang C. Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects. Cell Host & Microbe. 2025;33(6):836-853. doi:10.1016/j.chom.2025.04.020
BibTeX
@article{Luo2025,
author = {Luo, Xi and Wang, Kai and Jiang, Changtao},
title = {Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects},
journal = {Cell Host & Microbe},
year = {2025},
volume = {33},
number = {6},
pages = {836--853},
doi = {10.1016/j.chom.2025.04.020}
}
EUVIMED